Cancer is most commonly referred to as a state in which there is uncontrollable cell division. In today’s society, we try to tackle the pathways that are affected by a variety of cancers. For our project, we decided to choose lung cancer and in specifically, non-small cell lung cancer. According to the American Cancer Society about 80%-85% suffer from non-small cell lung cancer. It is very common and can be subdivided into Squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. We are focusing on Kras and its association with lung adenocarcinoma. We will also be discussing Keap1 and AATF. This type of cancer is known to be widespread and lethal. Our challenge will be in delivering a treatment that would only target the cancer cells. An idea we are looking at in this moment is to have a drug that will be delivered intravenous so that we may target the lungs via the pulmonary vein. Non-small cell lung cancer also referred to as NSCLC is a cancer which will be able to build off since it is also known to be metastatic.
Recent comments